CRYPTORCHIDISM IN CHILDREN: TIMING OF ORCHIDOPEXY AND LONG-TERM RISKS OF INFERTILITY AND TESTICULAR CANCER

Authors

  • Sherov Xondamir Oybek o’g’li Samarkand State Medical University Faculty of General Medicine, group 617 +998930054147 / sherovxondamir@gmail.com Author
  • Ne’matullayev Temurbek Baxodirovich Samarkand State Medical University Faculty of Pediatrics, group 526 +998933093103 / nematullaevtemurbek@gmail.com Author
  • Eshboyeva Muxtasar Vafoqul qizi Samarkand State Medical University Faculty of General Medicine, group 512 +998975752911 / dr.muxtasar@gmail.com Author

Keywords:

cryptorchidism, undescended testis, orchidopexy, infertility, testicular cancer, primary care, pediatric urology

Abstract

Cryptorchidism (undescended testis) is one of the most common congenital anomalies in boys and is associated with later infertility and testicular cancer. This review summarizes current recommendations on the timing of surgical correction, the evaluation of palpable and nonpalpable testes, and the reasons for delayed treatment, based on guidelines and published cohort studies. Consensus statements recommend orchidopexy between 6 and 18 months of age, and European guidance favors surgery before 12 months and by 18 months at the latest. Histological changes in the undescended testis, such as germ cell loss and interstitial fibrosis, progress with age and may become irreversible after the first year of life. Nevertheless, large reports indicate that 58–83% of boys worldwide undergo orchidopexy after 18 months, and in a series of 283 cases the mean age at surgery was 4.8 ± 5.6 years, with later surgery when the anomaly was first noticed by caregivers rather than by clinicians. Improved screening in primary care, avoidance of unnecessary imaging and counseling of patients about long-term risks are the priority measures.

References

1. American Urological Association. (2025). Evaluation and treatment of cryptorchidism. https://www.auanet.org/guidelines-and-quality/guidelines/cryptorchidism-guideline

2. European Association of Urology. (2025). EAU/ESPU guidelines on paediatric urology: Management of undescended testes. EAU.

3. Cryptorchidism. (2024). In StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK470270/

4. A narrative review of the history and evidence-base for the timing of orchidopexy for cryptorchidism. (2021). Journal of Pediatric Urology. PubMed PMID 33551366. https://pubmed.ncbi.nlm.nih.gov/33551366/

5. Does the initial source of recognition — clinician versus caregiver — affect the age at orchidopexy for undescended testis? A retrospective comparative analysis of 283 cases. (n.d.). https://pmc.ncbi.nlm.nih.gov/articles/PMC13526761/

6. Timing of paediatric orchidopexy in universal healthcare systems: International administrative data cohort study. (n.d.). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7709362/

7. Association between male genital anomalies and adult male reproductive disorders: A population-based data linkage study spanning more than 40 years. (2018). The Lancet Child & Adolescent Health. https://www.sciencedirect.com/science/article/abs/pii/S2352464218302542

Downloads

Published

2026-09-20